Mortality Predictor with sPAP in Elderly Critically Ill with Severe COVID-19 Pneumonia

mdpi.com

Mortality in general ARDS patients remains high, with many experiencing long-lasting sequelae. Numerous studies have been conducted to identify predictors of mortality in COVID-19 patients, particularly regarding right ventricular hemodynamics. However, most of these studies have focused on short-term mortality, as we have previously explored in detail.

Our current study demonstrates the continued deleterious effect of elevated systolic pulmonary artery pressure (sPAP) at ICU admission on elderly critically ill COVID-19 patients.

We believe that large long-term studies are urgently needed, as a significant portion of the population has been infected with SARS-CoV-2, even though the COVID-19 pandemic is (fortunately) over.

While our study focused on extreme cases (only critically ill patients), better long-term data will help healthcare and long-term care providers better direct their efforts.

Read More